ADORA2A and Parkinson disease: The striatal distribution of adenosine A2A receptors and the antagonistic molecular and behavioral interactions between adenosine and dopamine receptors provide a strong basis for the clinical observation that A2A receptor antagonists enhance motor activity in PD [24].